title: [CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].
authors.affiliation: Charité, Universitätsmedizin Berlin.
authors.forename: Hanno
authors.initials: H
authors.lastname: Riess
authors.affiliation: Charité, Universitätsmedizin Berlin.
authors.forename: Marianne
authors.initials: M
authors.lastname: Sinn
authors.affiliation: Charité, Universitätsmedizin Berlin.
authors.forename: Stephan
authors.initials: S
authors.lastname: Kreher
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage* / Q000009:adverse effects; D017060:Patient Satisfaction; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban